Guidance

MI4A Project Overview

A World Health Organization (WHO) initiative, Market Information for Access to Vaccines (MI4A), has been launched to contribute to the achievement of Strategic Development Goal 3.8 (Universal Health Coverage target) by enhancing access to safe, effective, quality, and affordable vaccines for all. MI4A is part of the broader WHO effort to ensure availability of Essential Medicines and responds to specific requests from Member States and the WHO Strategic Advisory Group of Experts on Immunization (SAGE) to address vaccine market information gaps.

Languages

  • English

Publisher

WHO

Type

Guidance

Categories

  • Programme management

Topic references

EPI-CORE-MI4A

TitleAuthorYearTypeLanguage
Global Market Study: BCG Vaccine - May 2019World Health Organization (WHO)2019ReportEnglish
Global Market Study: Diphtheria and tetanus-containing vaccines - 2019World Health Organization (WHO)2019ReportEnglish
Global Market Study: HPV - 2020World Health Organization (WHO)2020ReportEnglish
Global Market Study: Human Rabies vaccines - 2020World Health Organization (WHO)2020ReportEnglish
Global Market Study: Measles-containing vaccines (MCV) - 2020World Health Organization (WHO)2020ReportEnglish
Global Market Study: Meningococcal meningitis vaccines - 2019World Health Organization (WHO)2019ReportEnglish
Global Market Study: Pneumococcal Conjugate (PCV) and Polysaccharide (PPV) vaccines - 2020World Health Organization (WHO)2020ReportEnglish
Global Market Study: Typhoid vaccines - 2020World Health Organization (WHO)2020ReportEnglish
Global Vaccine Market Report - 2020World Health Organization (WHO)2020ReportEnglish
MI4A Project OverviewWorld Health Organization (WHO)GuidanceEnglish
MI4A Vaccine Purchase Data for Countries - 2022World Health Organization (WHO)DatasheetEnglish
Vaccine Price Report - 2017World Health Organization (WHO)2017ReportEnglish
Vaccine Pricing: Gavi Fully Self Financing and Accelerated Transition CountriesWorld Health Organization (WHO)2018ReportEnglish